Literature DB >> 19353387

Prevalence of industry support and its relationship to research integrity.

Patricia M Tereskerz1, Ann B Hamric, Thomas M Guterbock, Jonathan D Moreno.   

Abstract

Most U.S. clinical trials are funded by industry. Opportunities exist for sponsors to influence research in ways that jeopardize research objectivity. The purpose of this study was to survey U.S. medical school faculty to assess financial arrangements between investigators and industry to learn about investigators' first hand knowledge of the effects of industry sponsorship on research. Here we show first-hand knowledge that compromises occurred in: research participants' well-being (9%), research initiatives (35%), publication of results (28%), interpretation of research data (25%), and scientific advancement (20%) because of industry support. Financial relationships with industry were prevalent and considered important to conducting respondents' research.

Entities:  

Mesh:

Year:  2009        PMID: 19353387      PMCID: PMC2758529          DOI: 10.1080/08989620902854945

Source DB:  PubMed          Journal:  Account Res        ISSN: 0898-9621            Impact factor:   2.622


  23 in total

1.  Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research.

Authors:  Patricia M Tereskerz; Jonathan Moreno
Journal:  Account Res       Date:  2005 Apr-Jun       Impact factor: 2.622

Review 2.  Methodologies for improving response rates in surveys of physicians: a systematic review.

Authors:  Jonathan B VanGeest; Timothy P Johnson; Verna L Welch
Journal:  Eval Health Prof       Date:  2007-12       Impact factor: 2.651

3.  Professionalism in medicine: results of a national survey of physicians.

Authors:  Eric G Campbell; Susan Regan; Russell L Gruen; Timothy G Ferris; Sowmya R Rao; Paul D Cleary; David Blumenthal
Journal:  Ann Intern Med       Date:  2007-12-04       Impact factor: 25.391

4.  Scientific misconduct from the perspective of research coordinators: a national survey.

Authors:  Erica R Pryor; Barbara Habermann; Marion E Broome
Journal:  J Med Ethics       Date:  2007-06       Impact factor: 2.903

5.  The evolution of clinical trials: inclusion and representation.

Authors:  P A Rochon; P B Berger; M Gordon
Journal:  CMAJ       Date:  1998-12-01       Impact factor: 8.262

Review 6.  Influences on the quality of published drug studies.

Authors:  L A Bero; D Rennie
Journal:  Int J Technol Assess Health Care       Date:  1996       Impact factor: 2.188

7.  Conflict of interest in the debate over calcium-channel antagonists.

Authors:  H T Stelfox; G Chua; K O'Rourke; A S Detsky
Journal:  N Engl J Med       Date:  1998-01-08       Impact factor: 91.245

8.  Participation of life-science faculty in research relationships with industry.

Authors:  D Blumenthal; E G Campbell; N Causino; K S Louis
Journal:  N Engl J Med       Date:  1996-12-05       Impact factor: 91.245

Review 9.  Recent trends and controversies in industry-sponsored clinical trials.

Authors:  C R Reed; C A Camargo
Journal:  Acad Emerg Med       Date:  1999-08       Impact factor: 3.451

10.  A national survey of physician-industry relationships.

Authors:  Eric G Campbell; Russell L Gruen; James Mountford; Lawrence G Miller; Paul D Cleary; David Blumenthal
Journal:  N Engl J Med       Date:  2007-04-26       Impact factor: 91.245

View more
  3 in total

1.  Challenges to deep brain stimulation: a pragmatic response to ethical, fiscal, and regulatory concerns.

Authors:  Joseph J Fins; Gary S Dorfman; Joseph J Pancrazio
Journal:  Ann N Y Acad Sci       Date:  2012-07-23       Impact factor: 5.691

2.  Controversies concerning the diagnosis and treatment of bipolar disorder in children.

Authors:  Erik Parens; Josephine Johnston
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2010-03-10       Impact factor: 3.033

3.  Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study.

Authors:  Rosa Ahn; Alexandra Woodbridge; Ann Abraham; Susan Saba; Deborah Korenstein; Erin Madden; W John Boscardin; Salomeh Keyhani
Journal:  BMJ       Date:  2017-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.